Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: TRPV6 alleles do not influence prostate cancer progression

Figure 2

TRPV6 allele frequencies in prostate cancer patients. (A) Comparison of TRPV6 allele frequencies in salivary from Caucasian males and females, (n = 169, χ2 = 0.22, p > 0.1), (B) tissue samples from healthy males (n = 77) and prostate cancer patients (n = 141, χ2 = 0.23, p > 0.1), (C) tissue samples from early onset prostate cancer patients (age < 60) and late onset patients (age > 60) (n = 99, χ2 = 0.58, p > 0.1), (D) tissue samples from patients with low Gleason scores (<7) and high Gleason scores (>7) (n = 90, χ2 = 0.69, p > 0.1) and (E) tissue samples from patients with the tumour stages pT1-pT2 and patients with the tumour stages pT3-pT4 (n = 99, χ2 = 0.03, p > 0.1).

Back to article page